Cardinal Health Inc (CAH) Stock Price Today
Aura AI Summary
Key Stats
- $52.93BMarket Cap
- -Volume
- HealthSector
- $239.7152W High
- $146.0452W Low
- -Typical Hold Time
- $57.90BEnterprise Value
- 0.91%Div Yield
- -Trading Activity
Track Cardinal Health Inc (CAH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Cardinal Health Inc has traded between a low of $146.04 and a high of $239.71, highlighting its annual price range. Buy and sell Cardinal Health Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Most Recent News
Oportun named to CNBC's Top Fintech Companies 2026 list for third year in a row.
Oportun Financial Corporation has been recognized on CNBC's World's Top Fintech Companies 2026 list for the third consecutive year, highlighting its impact in the Wealth Technology category. The company is praised for its technology-driven tools that...

Class action lawsuit filed against PROCEPT BioRobotics over alleged misleading sales and inventory practices.
Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation and its executives, accusing them of misleading investors by inflating sales figures through an undisclosed discount program that caused excess ...

Class action lawsuit filed against Cogent Communications over misleading backlog and financial claims
Rosen Law Firm has filed a class action lawsuit on behalf of Cogent Communications stock purchasers from Feb 29, 2024 to May 1, 2026. The suit alleges Cogent misled investors by overstating its optical wavelength backlog, customer demand, and financi...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.